Clinical management
Clinical management 100
Orrell C, Hagins DP, Belonosova E, Porteiro N, Walmsley S, Falcó V, et al. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study. The Lancet HIV 2017.
Clinical management 101
Chirwa M, Ma R, Guallar C, Tariq S. Managing menopause in women living with HIV: A survey of primary care practitioners. Post Reprod Health 2017:2053369117712181.
Evidence for Contraceptive Options
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019 Jun 13. pii: S0140-6736(19)31288-7.
Watson S
Watson S, Namiba A, Lynn. The language of HIV: a guide for nurses. NHIVNA Best Practice. HIV Nursing 2019; 19(2): BP1–BP4.
Jaspal R
Jaspal R, Nambiar KZ, Delpech V, Tariq S. HIV and trans and non-binary people in the UK. Sex Transm Infect. 2018 Aug; 94(5):318-319.v
Bull L
Bull L, Tittle V, Rashid T, Nwokolo N. HIV and the menopause: A review. Post Reprod Health. 2018 Mar; 24(1):19-25.
Kowalska JD
Kowalska JD, Aebi-Popp K, Loutfy M, Post FA, Perez-Elias MJ, Johnson M, Mulcahy F; Women Against Viruses in Europe (WAVE) Working Group. Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group. HIV Med. 2018 Feb; 19(2):167-173.
Solomon D
Solomon D, Sabin CA, Mallon PWG, Winston A, Tariq S. Cardiovascular disease in women living with HIV: A narrative review. Maturitas. 2018 Feb; 108:58-70.
Raffe SF
Raffe SF, Savage C, Perry LA, Patel A, Keith T, Howell R, Bradley R, Bomont R, Fidler K, Gilleece Y. The management of HIV in pregnancy: A 10-year experience. Eur J Obstet Gynecol Reprod Biol. 2017 Mar; 210:310-313.
Finnerty F
Finnerty F, Walker-Bone K, Tariq S. Osteoporosis in postmenopausal women living with HIV. Maturitas. 2017 Jan; 95:50-54.
Clinical management 98
Andany, N. and Walmsley, S. What's new for antiretroviral treatment in women. Journal of Virus Eradication. 2016;2:67-77. http://viruseradication.com/journal-details/What's_new_for_antiretroviral_treatment_in_women
Clinical management 97
Bailey H, Thorne C, Malyuta R, et al. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health. 2014;14(1):993. http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-993
Clinical management 96
Best BM, Burchett S, Li H, et al. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/25959631
Clinical management 95
Blystad A, Moland KM. Technologies of hope? Motherhood, HIV and infant feeding in eastern Africa. Anthropology & Medicine. 2009;16(2):105-118. http://www.tandfonline.com/doi/abs/10.1080/13648470902940655
Clinical management 94
Boer, K., England, K., Godfried, M.H., et al. (2010) Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV medicine. European Collaborative Study, [Online] 11 (6), 368–378. Available from: doi:10.1111/j.1468-1293.2009.00800. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428890/
Clinical management 93
Boonyanurak P, Bunupuradah T, Wilawan K, et al. Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women. Menopause. 2012;19(7):820-824. http://www.ncbi.nlm.nih.gov/pubmed/22549170
Clinical management 99
Bynum, S. A., Wigfall, L. T., Brandt, H. M., Julious, C. H., Glover, S. H., & Hébert, J. R. (2016). Social and Structural Determinants of Cervical Health among Women Engaged in HIV Care. AIDS and Behavior, 1-9. https://www.ncbi.nlm.nih.gov/pubmed/26955821
Clinical management 101
Narasimhan, M., Orza, L., Welbourn, A., Bewley, S., Crone, T. and Vazquez, M. (2016). Sexual and reproductive health and human rights of women living with HIV: a global community survey. Bulletin of the World Health Organization, 94(4), pp.243-249. http://www.who.int/bulletin/volumes/94/4/14-150912.pdf [Accessed 2 Aug 2016]
Clinical management 92
Byrne, L., Fakoya, A. & Harding, K. (2012) HIV in pregnancy: an international perspective: HIV in pregnancy: an international perspective. The Obstetrician &Gynaecologist. [Online] 14 (1), 17–24. Available from: doi:10.1111/j.1744-4667.2011.00076. https://www.researchgate.net/publication/264371391_HIV_in_pregnancy_An_international_perspective
Clinical management 91
Calvet GA, Grinsztejn BG, Quintana Mde S, et al. Predictors of early menopause in HIV-infected women: a prospective cohort study. American journal of obstetrics and gynecology. 2015;212(6):765.e761-765.e713. http://www.ncbi.nlm.nih.gov/pubmed/25557206
Clinical management 90
Calvet GA, Velasque L, Luz PM, et al. Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil. PloS one. 2014;9(2):e89299. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089299
Clinical management 89
Carlsson-LallooEwa, Rusner Marie, MellgrenÅsa, and Berg Marie. Sexuality and Reproduction in HIV-Positive Women: A Meta-Synthesis. AIDS Patient Care and STDs. February 2016, 30(2): 56-69. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753620/
Clinical management 88
Carter, M.W., Kraft, J.M., Hatfield-Timajchy, K., Snead, M.C., et al. (2013) The reproductive health behaviors of HIV-infected young women in the United States: A literature review. AIDS patient care and STDs. [Online] 27 (12), 669–680. Available from: doi:10.1089/apc.2013.0208. http://www.ncbi.nlm.nih.gov/pubmed/24320012
Clinical management 87
Cournil, A., Van de Perre, P., Cames, C., de Vincenzi, I., et al. (2015) Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa). The Pediatric Infectious Disease Journal. [Online] 34 (2), 168–174. Available from: doi:10.1097/INF.0000000000000512. http://icrh.org/sites/default/files/00006454-201502000-00013.pdf
Clinical management 86
dePommerol M, Hessamfar M, Lawson-Ayayi S, et al. Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort. Int J STD AIDS. 2011;22(2):67-72. http://www.ncbi.nlm.nih.gov/pubmed/21427426
Clinical management 85
deRuiter et al British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review) DOI: 10.1111/hiv.12185 HIV Medicine (2014), 15 (Suppl. 4), 1–77 http://www.bhiva.org/documents/Guidelines/Pregnancy/2012/BHIVA-Pregnancy-guidelines-update-2014.pdf
Clinical management 84
Doherty T, Chopra M, Nkonki L, Jackson D, Greiner T. Effect of the HIV epidemic on infant feeding in South Africa: "When they see me coming with the tins they laugh at me". Bulletin of the World Health Organization. 2006;84:90-96. http://www.ncbi.nlm.nih.gov/pubmed/16501725
Clinical management 83
Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Breastfeeding While Taking Lamivudine or TenofovirDisoproxil Fumarate: A Review of the Evidence. Clinical Infectious Diseases. 2015;60(2):275-278. http://cid.oxfordjournals.org/content/early/2014/10/13/cid.ciu798.abstract
Clinical management 82
Elgalib A, Hegazi A, Samarawickrama A, et al. Pregnancy in HIV-infected teenagers in London. HIV Med. 2011;12(2):118-123. http://www.ncbi.nlm.nih.gov/pubmed/20807252
Osteoporosis in postmenopausal women living with HIV
Finnerty F, Walker-Bone K, Tariq S. Osteoporosis in postmenopausal women living with HIV. Maturitas. 2017;95:50-4.
Clinical management 81
Fowler, M., M Qin, SA Fiscus, JS Currier, et al. (2015) PROMISE: Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission. In: Prevention, Diagnosis and Treatment of Paedatric HIV Infection. 23 February 2015 Seattle, Washington, USA. http://www.croiconference.org/sessions/promise-efficacy-and-safety-2-strategies-prevent-perinatal-hiv-transmission
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016;375(18):1726-37.
Clinical management 80
French CE, Thorne C, Tariq S, Cortina-Borja M, Tookey PA. Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy? AIDS. 2014;28(9):1369-1372. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032213/
Clinical management 79
French C.E. T, P.A., Cortina-Borja, M., de Ruiter, A., Townsend, C.L., Thorne C. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women. AntivirTher. 2013;18(2):183-192. http://www.ncbi.nlm.nih.gov/pubmed/23475123
Clinical management 78
Gertsch A, Michel O, Locatelli I, et al. Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study. AIDS Patient Care STDS. 2013;27(4):208-210. http://www.ncbi.nlm.nih.gov/pubmed/23506310
Clinical management 77
Giles ML, Hellard ME, Lewin SR, O'Brien ML. The "work" of women when considering and using interventions to reduce mother-to-child transmission (MTCT) of HIV. AIDS Care. 2009;21(10):1230-1237. http://www.ncbi.nlm.nih.gov/pubmed/20024698
Clinical management 100
Holstad, M. M., Spangler, S., Higgins, M., Dalmida, S. G., & Sharma, S. (2016). Psychosocial Characteristics Associated with Both Antiretroviral Therapy Adherence and Risk Behaviors in Women Living with HIV. AIDS Behav, 20(5), 1084-1096. http://link.springer.com/article/10.1007/s10461-015-1209-5
Clinical management 76
Homsy, J., Moore, D., Barasa, A., Were, W., et al. (2010) Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). [Online] 53 (1), 28–35. http://www.ncbi.nlm.nih.gov/pubmed/19797972
Clinical management 75
Huntington SE, Thorne C, Bansi LK, et al. Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care at 13 large UK clinics. AIDS. 2013;27(1):95-103. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495056/
Clinical management 74
Huntington SE, Bansi LK, Thorne C, et al. Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS. 2011;25(13):1647-1655. http://www.ncbi.nlm.nih.gov/pubmed/21673558
Clinical management 73
Huntington S, Thorne C, Newell M-L, et al. The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy. Aids. 2015;29(17):2269-2278. http://www.ncbi.nlm.nih.gov/pubmed/26544700
Clinical management 72
Huntington S, Thorne C, Newell ML, et al. Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy. AIDS. 2015. http://www.ncbi.nlm.nih.gov/pubmed/25710412
Clinical management 71
ICW Global, GNP+, COWLHA Malawi, and ICW East Africa, (2013). Understanding The Perspectives And/Or Experiences Of Women Living With HIV Regarding Option B+ In Uganda & Malawi In Support Of The Forthcoming Who Consolidated ARV Guidelines. http://www.gnpplus.net/assets/2013-Option-B+-Report-GNP-and-ICW.pdf
HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada
Ion A, Wagner AC, Greene S, Loutfy MR. HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care. 2017;29(2):137-44.
Clinical management 69
Kanapathipillai R, Hickey M, Giles M. Human immunodeficiency virus and menopause. Menopause. 2013;20(9):983-990. http://www.ncbi.nlm.nih.gov/pubmed/23531684
Clinical management 68
Katz IT, Shapiro R, Li D, et al. Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2010;54(1):27-34. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860013/
Clinical management 67
Kelly C, Alderdice F, Lohan M, Spence D. 'Every pregnant woman needs a midwife'-The experiences of HIV affected women in maternity care. Midwifery. 2012;29(2):132-138. http://www.ncbi.nlm.nih.gov/pubmed/23149240
Clinical management 66
Kelly C, Alderdice F, Lohan M, Spence D. Creating continuity out of the disruption of a diagnosis of HIV during pregnancy. Journal of clinical nursing. 2012;21(11-12):1554-1562. http://www.ncbi.nlm.nih.gov/pubmed/22458718
Clinical management 65
Kennedy VL, Serghides L, Raboud JM, et al. The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada. AIDS Care. 2014;26(6):777-784. http://www.ncbi.nlm.nih.gov/pubmed/24206065
Clinical management 64
Knudsen-Strong, E. From Pregnancy, to Baby and Beyond: Preliminary Findings from an Evaluation of the Pilot Programme, 2011, Positively UK. http://positivelyuk.org/wp-content/uploads/2014/11/Pos-UK-Pregnancy-Project-Evaluation-Report-Aug11.pdf
Clinical management 63
Kourtis, A.P., Schmid, C.H., Jamieson, D.J. & Lau, J. (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (London, England). [Online] 21 (5), 607–615. http://www.ncbi.nlm.nih.gov/pubmed/17314523
Clinical management 62
Kulasegaram, A D’Arminio Monforte, J Valdez Madruga, I Krznaric, et al. (2015) Reproductive choices of women with HIV-1 Infection: the ELLA study. In: [Online]. July 2015 Vancouver, Canada. http://pag.ias2015.org/Search/Index
Clinical management 61
Kumar, S., Gruskin, S., Khosla, R. &Narasimhan, M. (2015) Human rights and the sexual and reproductive health of women living with HIV – a literature review. Journal of the International AIDS Society. [Online] 18 (6(Suppl 5)) http://www.jiasociety.org/index.php/jias/article/view/20290/html
Clinical management 60
Looby SE, Shifren J, Corless I, et al. Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women. Menopause, 2014: 403-9 http://www.ncbi.nlm.nih.gov/pubmed/23820600
Clinical management 59
Looby SE. Menopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implications. J Assoc Nurses AIDS Care. 2012;23(3):195-203. http://www.ncbi.nlm.nih.gov/pubmed/21924646
Clinical management 58
Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d'Arminio Monforte A. Caring for women living with HIV: gaps in the evidence. J Int AIDS Soc. 2013;16(1):18509. http://www.jiasociety.org/index.php/jias/article/view/18509
Clinical management 57
Lui-Filho JF, Valadares AL, Gomes Dde C, Amaral E, Pinto-Neto AM, Costa-Paiva L. Menopausal symptoms and associated factors in HIV-positive women. Maturitas. 2013;76(2):172-178. http://www.ncbi.nlm.nih.gov/pubmed/23993758
Clinical management 56
Luzuriaga, K. &Mofenson, L.M. (2016) Challenges in the Elimination of Pediatric HIV-1 Infection. New England Journal of Medicine. 374 (8), 761–770. http://www.nejm.org/doi/full/10.1056/NEJMra1505256?af=R&rss=currentIssue
Clinical management 55
Maki PM, Rubin LH, Cohen M, et al. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus–infected and human immunodeficiency virus–uninfected women. Menopause. 2012;19(11):1215-1223. http://www.ncbi.nlm.nih.gov/pubmed/22872013
Clinical management 54
Mandelbrot L, Tubiana R, Le Chenadec J, et al. No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception. Clin Infect Dis. 2015;61(11):1715-1725. http://www.ncbi.nlm.nih.gov/pubmed/26197844
Clinical management 53
Marazzi, M.C., Nielsen-Saines, K., Buonomo, E., Scarcella, P., et al. (2009) Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. The Pediatric Infectious Disease Journal. [Online] 28 (6), 483–487. http://www.ncbi.nlm.nih.gov/pubmed/19483516
Clinical management 52
McDonald K, Kirkman M. HIV-positive women in Australia explain their use and non-use of antiretroviral therapy in preventing mother-to-child transmission. AIDS Care. 2011;23(5):578-584. http://www.ncbi.nlm.nih.gov/pubmed/20824555
Clinical management 51
McFall AM, Dowdy DW, Zelaya CE, et al. Understanding the Disparity: Predictors of Virologic Failure in Women Using Highly Active Antiretroviral Therapy Vary by Race and/or Ethnicity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013;64(3):289-298 210.1097/QAI.1090b1013e3182a1095e1099. http://www.ncbi.nlm.nih.gov/pubmed/23797695
Clinical management 50
McKnight, U. & Van der Zaag, A. C. (2015) “When Debility Provides a Future: preventing vertical transmission of HIV”; Journal Article Palgrave Macmillan 2015 11 Fem Rev 111 1 124-139 http://www.palgrave-journals.com/fr/journal/v111/n1/abs/fr201537a.html
Clinical management 102
McLeish, J., & Redshaw, M. (2016). 'We have beaten HIV a bit': a qualitative study of experiences of peer support during pregnancy with an HIV Mentor Mother project in England. BMJ Open, 6(6), e011499. http://bmjopen.bmj.com/content/6/6/e011499
Clinical management 49
Mmeje O, Njoroge B, Cohen CR, Temmerman M, Vermund SH, van der Poel S. Achieving Pregnancy Safely in HIV-Affected Individuals and Couples: An Important Strategy to Eliminate HIV Transmission From Mother-To-Child and Between Sexual Partners. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2015;70(4):e155-e159. http://www.ncbi.nlm.nih.gov/pubmed/26334740
Clinical management 48
Mofenson, L.M., Lambert, J.S., Stiehm, E.R., Bethel, J., et al. (1999) Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New England Journal of Medicine. 341 (6), 385–393 http://www.ncbi.nlm.nih.gov/pubmed/10432323
Clinical management 47
Momplaisir FM, Brady KA, Fekete T, Thompson DR, Diez Roux A, Yehia BR. Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV. PloS one. 2015;10(7):e0132262. http://www.ncbi.nlm.nih.gov/pubmed/26132142
Clinical management 46
Newell ML, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. CurrOpin HIV AIDS. 2013;8(5):504-510. http://www.ncbi.nlm.nih.gov/pubmed/23743789
Clinical management 45
Newell, M., Dunn, D., Peckham, C., Semprini, A., et al. (1996) Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS (London, England). 10 (14), 1675–1681 http://www.ncbi.nlm.nih.gov/pubmed/8970688
Clinical management 44
Orza, L., Welbourn, A., Bewley, S., Crone, E. and Vazquez, M. (2015). Building a safe house on firm ground: key findings from a global values and preferences survey regarding the sexual and reproductive health and human rights of women living with HIV. Salamander Trust. http://salamandertrust.net/resources/BuildingASafeHouseOnFirmGroundFINALreport190115.pdf
Clinical management 43
Panditrao M, Darak S, Jori V, Kulkarni S, Kulkarni V. Barriers associated with the utilization of continued care among HIV-infected women who had previously enrolled in a private sector PMTCT program in Maharashtra, India. AIDS Care. 2015:1-7. http://www.ncbi.nlm.nih.gov/pubmed/25559362
Clinical management 42
Patterson KB, Cohn SE, Uyanik J, Hughes M, Smurzynski M, Eron JJ. Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies. Clin Infect Dis. 2009;49(3):473-476. http://cid.oxfordjournals.org/content/49/3/473.full
Clinical management 41
Paxton, S. (2012). Positive and pregnant: how dare you - A study on access to reproductive and maternal health care for women living with HIV in Asia. Asia Pacific Network of People living with HIV. Available at: http://www.aidsdatahub.org/sites/default/files/documents/positive_and_pregnant_2012.pdf
Clinical management 40
Perry M, Taylor GP, Sabin CA, et al. Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26200570
Clinical management 39
Peters H, Byrne L, De Ruiter A, et al. Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study. BJOG: An International Journal of Obstetrics & Gynaecology. 2015:n/a-n/a. http://www.ncbi.nlm.nih.gov/pubmed/26011825
Clinical management 38
Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a Systematic Review. AIDS. 2012. http://www.ncbi.nlm.nih.gov/pubmed/23135169
Clinical management 37
Phillips, S.J., Polis, C.B. & Curtis, K.M. (2016) The safety of hormonal contraceptives for women living with HIV and their sexual partners. Contraception. [Online] 93 (1), 11–16. http://www.ncbi.nlm.nih.gov/pubmed/26515194
Clinical management 36
Perry M, Taylor GP, Sabin CA, et al. Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26200570
Clinical management 35
Peters H, Byrne L, De Ruiter A, et al. Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study. BJOG: An International Journal of Obstetrics & Gynaecology. 2015:n/a-n/a. http://www.ncbi.nlm.nih.gov/pubmed/26011825
Clinical management 34
Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a Systematic Review. AIDS. 2012. http://www.ncbi.nlm.nih.gov/pubmed/23135169
Clinical management 33
Phillips, S.J., Polis, C.B. & Curtis, K.M. (2016) The safety of hormonal contraceptives for women living with HIV and their sexual partners. Contraception. [Online] 93 (1), 11–16. http://www.ncbi.nlm.nih.gov/pubmed/26515194
Clinical management 32
Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27(4):493-505. http://www.sciencedirect.com/science/article/pii/S001078241400571X
Clinical management 31
Powis, K.M., Kitch, D., Ogwu, A., Hughes, M.D., et al. (2011) Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy. Journal of Infectious Diseases. [Online] 204 (4), 506–514. http://www.ncbi.nlm.nih.gov/pubmed/21791651
Clinical management 30
Psaros C, Remmert JE, Bangsberg DR, Safren SA, Smit JA. Adherence to HIV Care After Pregnancy Among Women in Sub-Saharan Africa: Falling Off the Cliff of the Treatment Cascade. Current HIV/AIDS Reports. 2015:1-5. http://www.ncbi.nlm.nih.gov/pubmed/25620530
Clinical management 29
Rachas A, Warszawski J, Le Chenadec J, et al. Does pregnancy affect the early response to cART? AIDS. 2013;27(3):357-367. http://www.ncbi.nlm.nih.gov/pubmed/23079802
Clinical management 28
Rahangdale L, Stewart A, Stewart RD, et al. Pregnancy Intentions Among Women Living With HIV in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2014;65(3):306-311 310.1097/QAI.0000000000000014. http://www.ncbi.nlm.nih.gov/pubmed/24525467
Clinical management 27
Read, J.S. & Newell, M.-L. (2005) Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. In: The Cochrane Collaboration (ed.). Cochrane Database of Systematic Reviews. http://apps.who.int/rhl/reviews/langs/CD005479.pdf
Clinical management 26
Rosin C, Elzi L, Thurnheer C, et al. Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study. HIV Med. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25329751
Clinical management 25
Rubin LH, Sundermann EE, Cook JA, et al. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause. 2014;21(9):997-1006. http://www.ncbi.nlm.nih.gov/pubmed/24496085
Clinical management 24
Salamander Trust, (2014). Salamander Trust values and preferences survey: sexual and reproductive health and human rights for women living with HIV http://salamandertrust.net/resources/SalamanderSRHRWHOSurveyforCirculationENGLISHMay2014.pdf
Clinical management 23
Sanders LB. Women's voices: the lived experience of pregnancy and motherhood after diagnosis with HIV. J Assoc Nurses AIDS Care. 2008;19(1):47-57. http://www.ncbi.nlm.nih.gov/pubmed/18191768
Clinical management 22
Saunders P, Goodman AL, Smith CJ, et al. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)? HIV Med 2015. http://www.ncbi.nlm.nih.gov/pubmed/26140659
Clinical management 21
Scherzer R, Bacchetti P, Messerlian G, et al. Impact of CD4+ lymphocytes and HIV infection on Anti-Mullerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women. Am J ReprodImmunol. 2015;73(3):273-284. http://www.ncbi.nlm.nih.gov/pubmed/25339186
Clinical management 20
Shapiro, R.L., Hughes, M.D., Ogwu, A., Kitch, D., et al. (2010) Antiretroviral regimens in pregnancy and breast-feeding in Botswana. New England Journal of Medicine. 362 (24), 2282–2294. http://www.nejm.org/doi/full/10.1056/NEJMoa0907736
Sherr L, Molloy A, Macedo A, Croome N, Johnson MA. Ageing and menopause considerations for women with HIV in the UK. Journal of Virus Eradication. 2016;2(4):215-8.
Clinical management 19
Short, C.-E.S. & Taylor, G.P. (2014) Antiretroviral therapy and preterm birth in HIV-infected women. Expert Review of Anti-infective Therapy. [Online] 12 (3), 293–306. http://onlinelibrary.wiley.com/doi/10.1111/hiv.12083/abstract
Clinical management 18
Squires et al. WAVES, Elvitegravir (EVG)/Cobicistat (COBI)/Emtricitabine (FTC)/TenofovirDisoproxil Fumarate (TDF) Is Superior to Ritonavir (RTV)‒Boosted Atazanavir (ATV) Plus FTC/TDF in Treatment-Naïve Women With HIV-1 Infection (WAVES Study). http://pag.ias2015.org/Abstract/AbstractDetail/3557
Clinical management 17
Tariq S, Pillen A, Tookey PA, Brown AE, Elford J. The impact of African ethnicity and migration on pregnancy in women living with HIV in the UK: design and methods. BMC Public Health. 2012;12(1):596. http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-596
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women
Squires K, Kityo C, Hodder S, Johnson M, Voronin E, Hagins D, et al. Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study. The Lancet HIV. 2016;3(9):e410-e20.
Clinical management 16
Tariq S, Elford J, Cortina-Borja M, Tookey PA, On Behalf Of The National Study Of HIV in Pregnancy and Childhood. The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland. AIDS Care. 2012;28(8):978-985. http://www.ncbi.nlm.nih.gov/pubmed/22519823
Clinical management 15
Tariq S, Townsend CL, Cortina-Borja M, et al. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune DeficSyndr. 2011;57(4):326-333. http://www.ncbi.nlm.nih.gov/pubmed/21499113
Clinical management 14
Tariq, S., Elford, J., Tookey, P., Anderson, J., de Ruiter, A., O'Connell, R., &Pillen, A. (2016). “It pains me because as a woman you have to breastfeed your baby”: decision-making about infant feeding among African women living with HIV in the UK. Sexually transmitted infections, 2015. http://www.ncbi.nlm.nih.gov/pubmed/26757986
Clinical management 13
Tariq, S et al. (2016). The menopause transition in women living with HIV: current evidence and future avenues of research. Journal of virus eradication. http://viruseradication.com/journal-details/The_menopause_transition_in_women_living_with_HIV:_current_evidence_and_future_avenues_of_research/
Clinical management 12
Tariq, S et al. (2016). The impact of the menopause transition on the health and wellbeing of women living with HIV: a narrative review. Maturitas. 2016; 88:76-83. http://www.sciencedirect.com/science/article/pii/S0378512216300640
Clinical management 11
Taylor, G.P., Trust, U.K., Positively, U.K. & Trust, L. (2010) Position statement on infant feeding in the UK.British HIV Association (BHIVA) and Children’s HIV Association (CHIVA) http://chiva.org.uk/professionals/health/guidelines/mtct/feeding-statement
Clinical management 70
The International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 1999; 340:977-987 http://www.nejm.org/doi/full/10.1056/NEJM199904013401301
Clinical management 10
Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG. 2008;115(9):1078-1086. http://www.ncbi.nlm.nih.gov/pubmed/18503577
Clinical management 9
Townsend CL, Byrne L, Cortina-Borja M, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS. 2014;28(7):1049-1057. http://www.ncbi.nlm.nih.gov/pubmed/24566097
Clinical management 8
Townsend, C.L., Cortina-Borja, M., Peckham, C.S. &Tookey, P.A. (2007) Response to Kourtis et al. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 21 (13), 1831–1832. http://journals.lww.com/aidsonline/fulltext/2007/08200/response_to_kourtis_et_al___use_of_antiretroviral.27.aspx
Clinical management 7
Townsend, C., Schulte, J., Thorne, C., Dominguez, K., et al. (2010) Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG: An International Journal of Obstetrics &Gynaecology. [Online] 117 (11), 1399–1410. http://www.ncbi.nlm.nih.gov/pubmed/20716250
Clinical management 6
Treisman K, Jones FW, Shaw E. The experiences and coping strategies of United Kingdom-based African women following an HIV diagnosis during pregnancy. J Assoc Nurses AIDS Care. 2014;25(2):145-157. http://www.ncbi.nlm.nih.gov/pubmed/23523367
Clinical management 5
UNAIDS. Joint United Nations Programme on HIV/AIDS (2011) Countdown to zero: global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011-2015. Geneva, Switzerland, UNAIDS http://www.unaids.org/sites/default/files/media_asset/20110609_JC2137_Global-Plan-Elimination-HIV-Children_en_1.pdf
Clinical management 4
vanBenthem BH, Vernazza P, Coutinho RA, Prins M. The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS. 2002;16(6):919-924. http://www.ncbi.nlm.nih.gov/pubmed/11919494
Clinical management 3
Wall KM et al. Hormonal contraception, pregnancy, breastfeeding and risk of HIV disease progression among Zambian women. J Acquir Immune DeficSyndr. 2015 Sep 12. http://www.ncbi.nlm.nih.gov/pubmed/26379070
Clinical management 2
Wedi COO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. The Lancet HIV. 2015. http://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(15)00207-6/abstract
Clinical management 1
Yalamanchi S, Dobs A, Greenblatt RM. Gonadal function and reproductive health in women with human immunodeficiency virus infection. EndocrinolMetabClin North Am. 2014;43(3):731-741. http://www.ncbi.nlm.nih.gov/pubmed/25169564
Engagement in care
Puskas, Cathy M.; Kaida, Angela; Miller, Cari L.; Zhang, Wendy; Yip, Benita; Pick, Neora; Montaner, Julio S.G.; Hogg, Robert S. The gender gap: a longitudinal examination of men's and women's art adherence in british columbia, 2000-2014. AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001408 - https://www.ncbi.nlm.nih.gov/pubmed/28118206
Engagement in Care 28
Kronfli N, Lacombe-Duncan A, Wang Y, de Pokomandy A, Kaida A, Logie C, et al. Access and engagement in HIV care among a national cohort of women living with HIV in Canada. AIDS Care 2017; 29(10):1235-1242.
Ndaimani A, Chitsike
Ndaimani A, Chitsike I, Haruzivishe C, Stray-Pedersen B. An Exploration of Barriers and Enablers of Retention in a Program to Reduce Vertical Transmission of HIV at Health Centers in Zimbabwe. Int J Prev Med. 2019 May 17; 10:74.
Engagement in care 27
Aebi-Popp K, Kouyos R, Bertisch B, et al. Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26268702
Engagement in care 26
Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum Engagement in HIV Care: An Important Predictor of Long Term Retention in Care and Viral Suppression. Clin Infect Dis. 2015;61(12):1880-1887. http://cid.oxfordjournals.org/content/early/2015/08/10/cid.civ678
Engagement in care 25
Anderson J, Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care. 2004;16(1):95-105. http://www.ncbi.nlm.nih.gov/pubmed/14660147
Engagement in care 24
Anderson J, Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care. 2004;16(1):95-105. http://www.ncbi.nlm.nih.gov/pubmed/14660147
Engagement in care 23
ATHENA Network . In Women's Words: HIV Priorities for positive change. (2011) http://wecareplus.net/resources/InWomen%27sWordsFinal.pdf
Engagement in care 22
AVAC, ATHENA, Salamander Trust, AVAC, ATHENA. UNWomen, (2015). Key barriers to women’s access to HIV treatment: Making “Fast-Track” a reality. http://salamandertrust.net/resources/web_UNWomenetal_IAS%20treatment_access-4pp.pdf
Engagement in care 28
Bengtson, A. M., Chibwesha, C. J., Westreich, D., Mubiana-Mbewe, M., Chi, B. H., Miller, W. C., . . . Pettifor, A. (2016). A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period. AIDS Care, 28(8), 1035-1045. https://www.ncbi.nlm.nih.gov/pubmed/26887526
Engagement in care 21
Blackstock OJ, Blank AE, Fletcher JJ, Verdecias N, Cunningham CO. Considering Care-Seeking Behaviors Reveals Important Differences Among HIV-Positive Women Not Engaged in Care: Implications for Intervention. AIDS Patient Care and STDs. 2015;29(S1):S20-S26. http://www.ncbi.nlm.nih.gov/pubmed/25561307
Engagement in care 20
Blais M, Fernet M, Proulx-Boucher K, et al. Barriers to health-care and psychological distress among mothers living with HIV in Quebec (Canada). AIDS Care. 2015:1-8. http://www.ncbi.nlm.nih.gov/pubmed/25587793
Engagement in care 19
Blank AE, Fletcher J, Verdecias N, Garcia I, Blackstock O, Cunningham C. Factors Associated with Retention and Viral Suppression Among a Cohort of HIV+ Women of Color. AIDS Patient Care STDS. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25458205
Engagement in care 18
Boehme AK, Davies SL, Moneyham L, Shrestha S, Schumacher J, Kempf MC. A qualitative study on factors impacting HIV care adherence among postpartum HIV-infected women in the rural southeastern USA. AIDS Care. 2013. http://www.ncbi.nlm.nih.gov/pubmed/24116662
Engagement in care 17
Buchberg MK, Fletcher FE, Vidrine DJ, et al. A mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women. AIDS Patient Care STDS. 2015;29(3):126-132. http://www.ncbi.nlm.nih.gov/pubmed/25612217
Engagement in care 16
Clouse K, Pettifor A, Shearer K, et al. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Tropical medicine & international health : TM & IH. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23374278
Engagement in care 15
Dilmitis, S., Edwards, O., Hull, B., Margolese, S., Mason, N., Namiba, A., Nyambe, M., Paxton, S., Petretti, S., Ross, G., Welbourn, A. and Zakowics, A. (2012). Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. Journal of the International AIDS Society, 15(4(Suppl 2). http://www.jiasociety.org/index.php/jias/article/view/17990
Engagement in care 14
Doyal, Lesley, and Jane Anderson. “HIV-positive African Women Surviving in London: Report of a Qualitative Study”. Gender and Development 14 (1): 95–104. 2006 http://www.jstor.org/stable/20461119
Engagement in care 13
Doyal L, Anderson J'My fear is to fall in love again...' How HIV-positive African women survive in London. SocSci Med. 2005 Apr;60(8):1729-38. http://www.ncbi.nlm.nih.gov/pubmed/15686805
Engagement in care 12
Ferguson L, Lewis J, Grant AD, et al. Patient Attrition Between Diagnosis With HIV in Pregnancy-Related Services and Long-Term HIV Care and Treatment Services in Kenya: A Retrospective Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2012;60(3):e90-e97. http://www.ncbi.nlm.nih.gov/pubmed/22421747
Engagement in care 11
Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS. 2008;22(12):1503-1511. http://www.ncbi.nlm.nih.gov/pubmed/18614874
Engagement in care 10
Johnson M, Samarina A, Xi H, et al. Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care. 2015:1-11. http://www.ncbi.nlm.nih.gov/pubmed/26168817
Engagement in care 9
Lambert JS, Avramovic G, Jackson V, Sammon N, Lally S, Campbell FJ. Investigation Into the Reasons for Maternal Default from HIV Care Postpartum: A 3-Year Retrospective Review. AIDS Patient Care STDS. 2014;28(1):1-3. http://www.ncbi.nlm.nih.gov/pubmed/24380437
Engagement in care 8
Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039-2052. http://www.ncbi.nlm.nih.gov/pubmed/22951634
Engagement in care 7
Oron, B., Sebuwufu, G. and Welbourn, A. (2014). Stepping Stones for Peace and Prosperity. Strategies for Hope Trust and Salamander Trust. http://www.steppingstonesfeedback.org/index.php/page/Resources/gb?resourceid=79
Engagement in care 6
Paine, K., Hart, G., Jawo, M., Ceesay, S., Jallow, M., Morison, L., Walraven, G., McAdam, K. and Shaw, M. (2002). “˜Before we were sleeping, now we are awake”: Preliminary evaluation of the Stepping Stones sexual health programme in The Gambia. African Journal of AIDS Research, 1(1), pp.39-50. http://siteresources.worldbank.org/INTGENDER/Resources/MatthewShawAJARarticle.pdf
Engagement in care 5
Phillips T, Thebus E, Bekker LG, McIntyre J, Abrams EJ, Myer L. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study. J Int AIDS Soc. 2014;17(1):19242. http://www.ncbi.nlm.nih.gov/pubmed/25301494
Engagement in care 4
Positively UK, Women know best report, 24.9.2015 http://positivelyuk.org/women-know-best/
Engagement in care 3
Siddiqui R, Bell T, Sangi-Haghpeykar H, Minard C, Levison J. Predictive factors for loss to postpartum follow-up among low income HIV-infected women in Texas. AIDS Patient Care STDS. 2014;28(5):248-253. http://www.ncbi.nlm.nih.gov/pubmed/24720630
Engagement in care 2
Tariq S, Elford J, Cortina-Borja M, Tookey PA, On Behalf Of The National Study Of HIV in Pregnancy and Childhood. The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland. AIDS Care. 2012;28(8):978-985. http://www.ncbi.nlm.nih.gov/pubmed/22519823
Engagement in care1
Tariq, S., Elford, J., Chau, C., French, C., Cortina-Borja, M., Brown, A., Tookey, P. A. (2016). Loss to Follow-Up After Pregnancy Among Sub-Saharan Africa-Born Women Living With Human Immunodeficiency Virus in England, Wales and Northern Ireland: Results From a Large National Cohort. Sex Transm Dis, 43(5), 283-289. https://www.ncbi.nlm.nih.gov/pubmed/27100763
Engagement in care 1
Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS. 2014;28(4):589-598. http://www.ncbi.nlm.nih.gov/pubmed/24468999
Engagement in care2
Welbourn A, Orza L, Bewley S, Crone ET, Vazquez M, 2016 Sometimes you feel like you have no choice but to bear with it all” How much do we understand side-effects of ARVs on lives of women living with HIV? Poster. International AIDS Conference, Durban http://salamandertrust.net/wp-content/uploads/2014/05/SalamanderTrustAIDS2016__poster_finalTUPED272.pdf
Engagement in research
Engagement in research 11
Bucholz EM, Krumholz HM. Women in clinical research: what we need for progress. CircCardiovascQual Outcomes. 2015;8(2 Suppl 1):S1-3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415379/
Engagement in research 10
Corneli AL et al. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune DeficSyndr. 2015 Apr 15;68(5):578-84. http://www.ncbi.nlm.nih.gov/pubmed/25761233
Engagement in research 9
Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S. A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies. JAIDS. 2016;71(2):181-188. http://www.ncbi.nlm.nih.gov/pubmed/26361171
Engagement in research 8
Dilmitis, S., Edwards, O., Hull, B., Margolese, S., Mason, N., Namiba, A., Nyambe, M., Paxton, S., Petretti, S., Ross, G., Welbourn, A. and Zakowics, A. (2012). Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. Journal of the International AIDS Society, 15(4(Suppl 2). http://www.jiasociety.org/index.php/jias/article/view/17990
Engagement in research 7
ICW. Guidelines on ethical participatory research with HIV positive women. (2004). http://www.hivlawandpolicy.org/resources/guidelines-ethical-participatory-research-hiv-postive-women-international-community-women
Engagement in research 6
Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d'Arminio Monforte A. Caring for women living with HIV: gaps in the evidence. J Int AIDS Soc. 2013;16(1):18509. http://www.jiasociety.org/index.php/jias/article/view/18509
Engagement in research 12
Namiba, A, Orza, L, Bewley, S, Tyler Crone, E, Vazquez, M, Wellbourn, A. Ethical, strategic and meaningful involvement of women living with HIV starts at the beginning. Journal of Virus Eradication. 2016;2: 119-111. http://viruseradication.com/journal-details/Ethical,_strategic_and_meaningful_involvement_of_women_living_with_HIV_starts_at_the_beginning
Engagement in research 5
Namiba, A., Orza, L., Bewley, S., Crone, T., Vazquez, M. and Welbourn, A. (n.d.). “Welcome to our house”: The meaningful involvement of women living with HIV in WHO guideline development starts simply - at the beginning. Journal of Virus Eradication 2, 110-111.
Engagement in research 4
Narasimhan, M., Orza, L., Welbourn, A., Bewley, S., Crone, E. and Vazquz, M. (2015). Ensuring users values and preferences in WHO guidelines: Sexual and reproductive health and human rights of women living with HIV. http://www.jiasociety.org/index.php/jias/article/view/20290/html
Engagement in research 3
Positively UK, Women know best report, 24.9.2015 http://positivelyuk.org/women-know-best/
Engagement in research 2
Welbourn, A. (2014). WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment. BMJ, 348(2007), pp.f7601-f7601. http://www.bmj.com/content/348/bmj.f7601
Engagement in research 1
Westreich D, Rosenberg M, Schwartz S, Swamy G. Representation of women and pregnant women in HIV research: a limited systematic review. PloS one. 2013;8(8):e73398. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751870/
Gender-based violence
The Concept and Measurement of Violence against Women and Men
S. Walby, J. Towers, S Balderston, C Corradi, B Francis, M Heiskanen, K Helweg-Larsen, L Mergaert, P Olive, E Palmer, H Stöckl and S Strid, The Concept and Measurement of Violence against Women and Men, 14 Feb 2017, PDF available at: https://policypress.co.uk/the-concept-and-measurement-of-violence-against-women-and-men
A New Methodology to Measure Repeat Attacks Making Visible the Significance of Gender and Domestic Relations
Sylvia Walby, Jude Towers and Brian Francis , Is Violent Crime Increasing or Decreasing? A New Methodology to Measure Repeat Attacks Making Visible the Significance of Gender and Domestic Relations, Br J Criminol (2016) 56 (6): 1203-1234. DOI: https://doi.org/10.1093/bjc/azv131, https://academic.oup.com/bjc/article/56/6/1203/2415172/Is-Violent-Crime-Increasing-or-Decreasing-a-New
Screening for intimate partner violence in a London HIV clinic
Madge, S., Smith, C., Warren-Gash, C., Bayly, J., & Bartley, A. (2017). Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive. HIV Med, 18(1), 66-68. doi:10.1111/hiv.12404, https://www.ncbi.nlm.nih.gov/pubmed/27905674
Gender-based violence 22
AIDS Legal Network. If I knew what would happen I would have kept it to myself: Gender violence and HIV. (2012). http://www.endvawnow.org/uploads/browser/files/gender_violence_hiv__report_summary.pdf
Gender-based violence 21
AVAC, ATHENA, Salamander Trust, UNWomen, (2015). Key barriers to women’s access to HIV treatment: Making ‘Fast-Track’ a reality.
Gender-based violence 20
Campbell, J., Baty, M., Ghandour, R., Stockman, J., Francisco, L. and Wagman, J. (2008). The intersection of intimate partner violence against women and HIV/AIDS: a review. International Journal of Injury Control and Safety Promotion, 15(4), pp.221-231. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274697/
Gender-based violence 19
Bradley, J., Bhattacharjee, P., Ramesh, B., Girish, M. and Das, A. Evaluation of Stepping Stones as a tool for changing knowledge, attitudes and behaviours associated with gender, relationships and HIV risk in Karnataka, India. 2011 BMC Public Health, 11(1) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146862/
Gender-based violence 18
Dhairyawan R et al. Intimate partner violence in women living with HIV attending an inner city clinic in the UK: prevalence and associated factors. HIV Medicine, Volume 14, Issue 5, pages 303–310, May 2013. http://onlinelibrary.wiley.com/doi/10.1111/hiv.12009/full
Gender-based violence 17
Durevall, D. and Lindskog, A. (2015). Intimate partner violence and HIV in ten sub-Saharan African countries: what do the Demographic and Health Surveys tell us?.The Lancet Global Health, 3(1), pp.e34-e43. http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(14)70343-2/fulltext?rss=yes
Gender-based violence 16
Hale, F. and Vazquez, M. (2011). Violence Against Women living with HIV/AIDS: A Background Paper. Development Connections and ICW with the Support of UNWomen.
http://salamandertrust.net/wp-content/uploads/2012/12/VAPositiveWomenBkgrdPaperMarch2011.pdf
Gender-based violence 15
Hatcher, A., Smout, E., Turan, J., Christofides, N. and Stoeckl, H. (2015). Intimate partner violence and engagement in HIV care and treatment among women. AIDS, p.1. http://www.ncbi.nlm.nih.gov/pubmed/26353027
Gender-based violence 14
Human Rights Watch.Hidden in the mealie meal: Gender-Based Abuses and Women’s HIV Treatment in Zambia. (2007) https://www.hrw.org/sites/default/files/reports/zambia1207web.pdf
Gender-based violence 13
Hutchinson, J. and Perry, G. (2012). Violence as a cause and consequence of women living with HIV in England. Sophia Forum.
http://sophiaforum.net/wp-content/uploads/2013/02/Finalweb_SophiaForum_HIV_GBVreport2013.pdf
Gender-based violence 23
Ion, A., Wagner, A. C., Greene, S., Loutfy, M. R., & Team, H. I. V. M. S. (2016). HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care, 1-8. https://www.ncbi.nlm.nih.gov/pubmed/27449254
Gender-based violence 12
Li, Y., Marshall, C., Rees, H., Nunez, A., Ezeanolue, E. and Ehiri, J. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis.2014, Journal of the International AIDS Society, 17(1). http://www.jiasociety.org/index.php/jias/article/view/18845
Gender-based violence 11
Mwanza, J. (2012). Baseline report on intimate partner violence amongst people living with HIV. COWLHA Malawi. http://steppingstonesfeedback.org/resources/25/IPVCOWLHAREPORTFINAL.pdf
Gender-based violence 10
Orza, L., Bewley, S., Chung, C., Crone, E., Nagadya, H., Vazquez, M. and Welbourn, A. (2015). “Violence. Enough already”: findings from a global participatory survey among women living with HIV. Journal of the International AIDS Society, 18(Suppl 5). http://www.jiasociety.org/index.php/jias/article/view/20285
Gender-based violence 9
Orza, L., Welbourn, A., Bewley, S., Crone, E. and Vazquez, M. (2015). Building a safe house on firm ground: key findings from a global values and preferences survey regarding the sexual and reproductive health and human rights of women living with HIV. Salamander Trust.
Gender-based violence 8
Osinde, M., Kaye, D. and Kakaire, O. (2011). Intimate partner violence among women with HIV infection in rural Uganda: critical implications for policy and practice. BMC Women's Health, 11(1), p.50. http://bmcwomenshealth.biomedcentral.com/articles/10.1186/1472-6874-11-50
Gender-based violence 7
Paxton, S. (2012). Positive and pregnant: how dare you - A study on access to reproductive and maternal health care for women living with HIV in Asia. Asia Pacific Network of People living with HIV. http://www.aidsdatahub.org/sites/default/files/documents/positive_and_pregnant_2012.pdf
Gender-based violence 6
Stadler J et al Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa. Social Science & Medicine 2014 June; Volume 110, pp. 49–55 http://www.sciencedirect.com/science/article/pii/S0277953614001907
Gender-based violence 5
Welbourn, A. (2014). WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment. BMJ, 348(2007), pp.f7601-f7601. http://www.bmj.com/content/348/bmj.f7601
Gender-based violence 4
16 ideas for addressing violence against women in the context of the HIV epidemic: a programming tool. (2013). Geneva: WHO/UNAIDS. Available at: http://apps.who.int/iris/bitstream/10665/95156/1/9789241506533_eng.pdf
Gender-based violence 3
WHO, Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual violence. (2013). http://apps.who.int/iris/bitstream/10665/85239/1/9789241564625_eng.pdf?ua=1
Gender-based violence 2
WHO Intimate Partner Violence during pregnancy: information sheet. (2011) WHO. http://whqlibdoc.who.int/hq/2011/WHO_RHR_11.35_eng.pdf
Gender-based violence 1
Willie, T., Overstreet, N., Sullivan, T., Sikkema, K. and Hansen, N. (2015). Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse. Behavioral Medicine, pp.00-00. http://www.ncbi.nlm.nih.gov/pubmed/26010763
HIV prevention
HIV Prevention
Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, et al. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. The Lancet HIV 2017.
Aaron E
Aaron E, Blum C, Seidman D, Hoyt MJ, Simone J, Sullivan M, Smith DK. Optimizing Delivery of HIV Pre-exposure Prophylaxis for Women in the United States. AIDS Patient Care STDS. 2018 Jan; 32(1):16-23.
Abdool
Abdool Karim SS, Passmore JS, Baxter C. The microbiome and HIV prevention strategies in women. Curr Opin HIV AIDS. 2018 Jan; 13(1):81-87.
HIV Prevention 18
Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV. AIDS patient care and STDs. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25513954
HIV Prevention 17
Baeten, J.M., Donnell, D., Ndase, P., Mugo, N.R., et al. (2012) Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. New England Journal of Medicine. [Online] 367 (5), 399–410. Available from: doi:10.1056/NEJMoa1108524. http://www.ncbi.nlm.nih.gov/pubmed/22784037
HIV Prevention 16
Bradley, J., Bhattacharjee, P., Ramesh, B., Girish, M. and Das, A. Evaluation of Stepping Stones as a tool for changing knowledge, attitudes and behaviours associated with gender, relationships and HIV risk in Karnataka, India. 2011 BMC Public Health, 11(1) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146862/
HIV Prevention 15
Chitembo, A., Dilmitis, S., Edwards, O., Foote, C., Griffiths, L., Moroz, S., Mungherera, L., Mworeko, L., Manchester, J., Margolese, S., Namiba, A., Paxton, S., Ross, G., Shahi, S. and Welbourn, A. (2012). Towards an HIV-free generation: getting to zero or getting to rights? Reproductive Health Matters, 20(39), pp.5-13. http://www.ncbi.nlm.nih.gov/pubmed/23177675
HIV Prevention 14
Corneli AL et al. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune DeficSyndr. 2015 Apr 15;68(5):578-84. http://www.ncbi.nlm.nih.gov/pubmed/25761233
HIV Prevention 13
Doggett EG et al. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction Journal of the International AIDS Society 2015, 18:20536 http://www.jiasociety.org/index.php/jias/article/view/20536
HIV Prevention 12
Gafos M et al. Intravaginal insertion in KwaZulu-Natal sexual practices and preferences in the context of microbicide gel use, Culture, Health and Sexuality, Volume 12 Issue 8, 2010, http://dx.doi.org/10.1080/13691058.2010.507876
HIV Prevention20
Grant, R. M., Sevelius, J. M., Guanira, J. V., Aguilar, J. V., Chariyalertsak, S., & Deutsch, M. B. (2016). Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 72(Suppl 3), S226. https://www.ncbi.nlm.nih.gov/pubmed/27429187
HIV Prevention 11
Jewkes, R., Nduna, M., Levin, J., Jama, N., Dunkle, K., Puren, A. and Duvvury, N. (2008). Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ, 337(aug07 1), pp.a506-a506. http://www.bmj.com/content/337/bmj.a506
HIV Prevention 10
Karim QA., Salim S. Karim, Frohlich, J.A., Grobler, A.C., et al. (2010) Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science [Online] 329 (5996), 1168–1174. Available from: doi:10.1126/science.1193748. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001187/
HIV Prevention 9
Marrazzo JM et al. Tenofovir-based pre-exposure prophylaxis for HIV infection among African women. N Engl J Med 372(6): 509-518. 2015. http://www.nejm.org/doi/full/10.1056/NEJMoa1402269
HIV Prevention 8
Montgomery C et al. Reframing microbicide acceptability: findings from the MDP301 Trial, Culture Health and Sexuality 2010 12: 6, 649-662 http://dx.doi.org/10.1080/13691051003736261
HIV Prevention 7
Ngure Kenneth, Heffron Renee, Curran Kathryn, Vusha Sophie, Ngutu Mariah, Mugo Nelly, Celum Connie, and Baeten Jared M. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation. AIDS Patient Care and STDs. February 2016, 30(2): 78-83. doi:10.1089/apc.2015.0259. http://online.liebertpub.com/doi/abs/10.1089/apc.2015.0259
HIV Prevention 6
Philpott A. et al (2006) ‘Pleasure and Prevention: when good sex is safe sex’ Reproductive Health Matters 14(28):23–31 https://secure.jbs.elsevierhealth.com/action/showCitFormats?pii=S0968-8080%2806%2928254-5&doi=10.1016%2FS0968-8080%2806%2928254-5&code=rhm-site
HIV prevention1
Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health, 11(7-8), 1060-1075. doi:10.1080/17441692.2016.1154085 https://www.ncbi.nlm.nih.gov/pubmed/26963756
HIV Prevention 5
Stadler, J. &Saethre, E. ‘Blockage and Flow: intimate experiences of condoms and microbicides in a South African Clinical trial’ in Culture, Health and Sexuality , 2011 , 13(1): 31-44 http://www.academia.edu/13510248/Blockage_and_flow_intimate_experiences_of_condoms_and_microbicides_in_a_South_African_clinical_trial
HIV Prevention 4
Stadler J et al Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa. Social Science & Medicine 2014 June; Volume 110, pp. 49–55 http://www.sciencedirect.com/science/article/pii/S0277953614001907
HIV Prevention 3
Syvertsen JL et al. Promise and Peril of Pre-Exposure Prophylaxis (PrEP): Using Social Science to Inform PrEP Interventions among Female Sex Workers. African Journal of Reproductive Health 2014 Sep; 18(3 0 0): 74–83. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605136/
HIV Prevention 2
The Pleasure Project, The global mapping of pleasure, 2004 http://thepleasureproject.org/downloads/GM_Final.pdf
HIV Prevention 1
van der Straten A et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. Journal of the International AIDS Society 17:19146, 2014. http://www.jiasociety.org/index.php/jias/article/view/19146/3951
Marginalised groups
The Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe
The Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013), AIDS. 2017. doi: 10.1097/QAD.0000000000001411, https://www.ncbi.nlm.nih.gov/pubmed/28118205
Marginalised groups 9
Anderson J, Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care. 2004;16(1):95-105. http://www.ncbi.nlm.nih.gov/pubmed/14660147
Marginalised Groups 10
Baral SD et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. The Lancet Infectious Diseases, 13: 214-22, 2013. http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70315-8/abstract
Marginalised groups 8
Blank AE, Fletcher J, Verdecias N, Garcia I, Blackstock O, Cunningham C. Factors Associated with Retention and Viral Suppression Among a Cohort of HIV+ Women of Color. AIDS Patient Care STDS. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25458205
Marginalised Groups 12
Deutsch MB et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. The Lancet HIV, 2015. http://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(15)00206-4/abstract
Marginalised groups 7
Doyal, Lesley, and Jane Anderson. “HIV-positive African Women Surviving in London: Report of a Qualitative Study”. Gender and Development 14 (1): 95–104. 2006 http://www.jstor.org/stable/20461119
Marginalised groups 6
Doyal L, Anderson J'My fear is to fall in love again...' How HIV-positive African women survive in London. SocSci Med. 2005 Apr;60(8):1729-38. http://www.ncbi.nlm.nih.gov/pubmed/15686805
Marginalised groups 5
Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS. 2008;22(12):1503-1511. http://www.ncbi.nlm.nih.gov/pubmed/18614874
Marginalised groups 17
Gerbier-Aublanc, M., Gosselin, A., & Group, P. S. (2016). Access to employment among African migrant women living with HIV in France: opportunities and constraints. AIDS Care, 28(8), 1058-1061. https://www.ncbi.nlm.nih.gov/pubmed/?term=Gerbier-Aublanc
Marginalised groups 18
Grant, R. M., Sevelius, J. M., Guanira, J. V., Aguilar, J. V., Chariyalertsak, S., & Deutsch, M. B. (2016). Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 72(Suppl 3), S226. https://www.ncbi.nlm.nih.gov/pubmed/27429187
Marginalised groups 4
Logie, C., James, L., Tharao, W. and Loutfy, M. (2013). Associations Between HIV-Related Stigma, Racial Discrimination, Gender Discrimination, and Depression Among HIV-Positive African, Caribbean, and Black Women in Ontario, Canada. AIDS Patient Care and STDs, 27(2), pp.114-122. http://online.liebertpub.com/doi/abs/10.1089/apc.2012.0296
Marginalised Groups 11
Mixuno Y et al. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health, online edition. DOI: 101.1089/lgbt.2014.0099 (2015). http://www.ncbi.nlm.nih.gov/pubmed/26788671
Marginalised Groups 13
National Center for Innovation in HIV Care. Transgender Women and Pre-Exposure Prophylaxis for HIV Prevention. 2015. https://careacttarget.org/sites/default/files/file-upload/resources/PrEP%20and%20Transgender%20Women%20NCIHC%20Brief.pdf
Marginalised groups 3
Ndirangu E, Evans C. Experiences of African Immigrant Women Living with HIV in the U.K.: Implications for Health Professionals. Journal of Immigrant and Minority Health. 2009;11(2):108-114. http://www.ncbi.nlm.nih.gov/pubmed/18205047
Marginalised groups 19
Poteat, T., Scheim, A., Xavier, J., Reisner, S., & Baral, S. (2016). Global epidemiology of HIV infection and related syndemics affecting transgender people. Journal of acquired immune deficiency syndromes (1999), 72(Suppl 3), S210. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969059/
Marginalised Groups 14
Poteat T HIV in transgender populations: charted and uncharted waters. Conference on Retroviruses and Opportunistic Infections (CROI), Boston, abstract 79, 2016. Webcast of presentation: http://www.croiwebcasts.org/console/player/29575?mediaType=podiumVideo&
The Role of Structural Barriers in Risky Sexual Behavior, Victimization and Readiness to Change
Raiford JL, Hall GJ, Taylor RD, Bimbi DS, Parsons JT. The Role of Structural Barriers in Risky Sexual Behavior, Victimization and Readiness to Change HIV/STI-Related Risk Behavior Among Transgender Women. AIDS Behav. 2016;20(10):2212-21.
Marginalised groups 20
Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health, 11(7-8), 1060-1075. doi:10.1080/17441692.2016.1154085 https://www.ncbi.nlm.nih.gov/pubmed/26963756
Marginalised groups 2
Syvertsen JL et al. Promise and Peril of Pre-Exposure Prophylaxis (PrEP): Using Social Science to Inform PrEP Interventions among Female Sex Workers. African Journal of Reproductive Health 2014 Sep; 18(3 0 0): 74–83. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605136/
Marginalised groups 1
Treisman K, Jones FW, Shaw E. The experiences and coping strategies of United Kingdom-based African women following an HIV diagnosis during pregnancy. J Assoc Nurses AIDS Care. 2014;25(2):145-157. http://www.ncbi.nlm.nih.gov/pubmed/23523367
Marginalised groups 15
Transgender Law Centre. Positively Trans: initial report of a national needs assessment of transgender and gender non-conforming people living with HIV. March 2016. http://transgenderlawcenter.org/programs/positively-trans/research
Marginalised groups 16
Wansom T, Guadamuz TE and Vasan S. Transgender populations and HIV: unique risks, challenges and opportunities. Journal of Virus Eradication. 2016;2: 87-93. http://viruseradication.com/journal-details/Transgender_populations_and_HIV:_unique_risks,_challenges_and_opportunities/
Mental health, psychological well-being and neurocognition
Mental health, psychological well-being and neurocognition 15
Taylor, T. N., Munoz-Plaza, C. E., Goparaju, L., Martinez, O., Holman, S., Minkoff, H. L., Golub, E. T. (2016). “The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV. Arch Sex Behav, 1-14. https://www.ncbi.nlm.nih.gov/pubmed/27220311
Mental health, psychological well-being and neurocognition 16
Rehm KE, Konkle-Parker D. Association of CD4+ T cell subpopulations and psychological stress measures in women living with HIV. AIDS Care 2017:1-5.
Vance DE
Vance DE, Rubin LH, Valcour V, Waldrop-Valverde D, Maki PM. Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study. Curr HIV/AIDS Rep. 2016 Dec; 13(6):399-411. Review. Erratum in: Curr HIV/AIDS Rep. 2017 Feb;14 (1):38.
Mental health, psychological well-being and neurocognition 14
Antelman, G., Kaaya, S., Wei, R., Mbwambo, J., Msamanga, G., Fawzi, W. and Smith Fawzi, M. (2007). Depressive Symptoms Increase Risk of HIV Disease Progression and Mortality Among Women in Tanzania. JAIDS Journal of Acquired Immune Deficiency Syndromes, 44(4), pp.470-477. http://www.ncbi.nlm.nih.gov/pubmed/17179766
Mental health, psychological well-being and neurocognition 13
Benoit AC, Light L, Burchell AN, et al. Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada. AIDS Care. 2014;26(6):694-701. http://www.ncbi.nlm.nih.gov/pubmed/24215281
Mental health, psychological well-being and neurocognition 12
Blais M, Fernet M, Proulx-Boucher K, et al. Barriers to health-care and psychological distress among mothers living with HIV in Quebec (Canada). AIDS Care. 2015:1-8. http://www.ncbi.nlm.nih.gov/pubmed/25587793
Mental health, psychological well-being and neurocognition 11
Kamen, C., Arganbright, J., Kienitz, E., Weller, M., Khaylis, A., Shenkman, T., Smith, S., Koopman, C. and Gore-Felton, C. (2015). HIV-related stigma: implications for symptoms of anxiety and depression among Malawian women. African Journal of AIDS Research, 14(1), pp.67-73. http://www.ncbi.nlm.nih.gov/pubmed/25920985
Mental health, psychological well-being and neurocognition 10
Kapetanovic S, Dass-Brailsford P, Nora D, Talisman N. Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review. AIDS Behav. 2014;18(6):1152-1173. http://www.ncbi.nlm.nih.gov/pubmed/24584458
Mental health, psychological well-being and neurocognition 9
Kotzé M, Visser M, Makin J, Sikkema K, Forsyth B. The coping strategies used over a two-year period by HIV-positive women who had been diagnosed during pregnancy. AIDS Care. 2013;25(6):695-701. http://www.ncbi.nlm.nih.gov/pubmed/23442202
Mental health, psychological well-being and neurocognition 8
Logie, C., James, L., Tharao, W. and Loutfy, M. (2013). Associations Between HIV-Related Stigma, Racial Discrimination, Gender Discrimination, and Depression Among HIV-Positive African, Caribbean, and Black Women in Ontario, Canada. AIDS Patient Care and STDs, 27(2), pp.114-122.
Mental health, psychological well-being and neurocognition 7
Maki PM, Rubin LH, Cohen M, et al. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus–infected and human immunodeficiency virus–uninfected women. Menopause. 2012;19(11):1215-1223. http://www.ncbi.nlm.nih.gov/pubmed/22872013
Mental health, psychological well-being and neurocognition 6
Orza, L., Bewley, S., Logie, C., Crone, E., Moroz, S., Strachan, S., Vazquez, M. and Welbourn, A. (2015). How does living with HIV impact on women’s mental health? Voices from a global survey. Journal of the International AIDS Society, 18(Suppl 5). http://www.jiasociety.org/index.php/jias/article/view/20289
Mental health, psychological well-being and neurocognition 5
Rubin LH, Sundermann EE, Cook JA, et al. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause. 2014;21(9):997-1006. http://www.ncbi.nlm.nih.gov/pubmed/24496085
Mental health, psychological well-being and neurocognition 4
Sanders LB. Women's voices: the lived experience of pregnancy and motherhood after diagnosis with HIV. J Assoc Nurses AIDS Care. 2008;19(1):47-57. http://www.ncbi.nlm.nih.gov/pubmed/18191768
Mental health, psychological well-being and neurocognition 3
Sheth SS, Coleman J, Cannon T, et al. Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV. AIDS Care. 2015;27(3):350-354. http://www.ncbi.nlm.nih.gov/pubmed/25616659
Mental health, psychological well-being and neurocognition 2
Treisman K, Jones FW, Shaw E. The experiences and coping strategies of United Kingdom-based African women following an HIV diagnosis during pregnancy. J Assoc Nurses AIDS Care. 2014;25(2):145-157. http://www.ncbi.nlm.nih.gov/pubmed/23523367
Mental health, psychological well-being and neurocognition 1
Willie, T., Overstreet, N., Sullivan, T., Sikkema, K. and Hansen, N. (2015). Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse. Behavioral Medicine, pp.00-00. http://www.ncbi.nlm.nih.gov/pubmed/26010763
Miscellaneous
Miscellaneous 12
Barnes, Applied drama and theatre as an interdisciplinary field in the context of HIV/AIDS in Africa. 2014 Amsterdam: Rodopi. https://www.wits.ac.za/media/news-migration/files/DFL%207th%20Africa%20Research%20Conference%20Programme%202014.pdf
Miscellaneous 11
Campbell C & Nair Y. From rhetoric to reality? Putting HIV and AIDS rights talk into practice in a South African rural community. Cult Health Sex. 2014;16(10):1216-30. http://www.ncbi.nlm.nih.gov/pubmed/25005486
Miscellaneous 10
Chadwick. Dand Salamander Trust. Seeking Safety: Stepping Stones in Malawi. (2013). [DVD] Malawi: COWLHA. http://steppingstonesfeedback.org/index.php/page/Resources/gb?resourceid=74
Miscellaneous 9
Dilmitis, S., Edwards, O., Hull, B., Margolese, S., Mason, N., Namiba, A., Nyambe, M., Paxton, S., Petretti, S., Ross, G., Welbourn, A. and Zakowics, A. (2012). Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. Journal of the International AIDS Society, 15(4(Suppl 2). http://www.jiasociety.org/index.php/jias/article/view/17990
Miscellaneous 8
Participatory HIV/AIDS Education Theatre in South Africa, in Dennis A. Francis (ed). 2011, Acting on HIV: Using Drama to Create Possibilities for Change, Rotterdam: Sense Publishers, pp. 1-14. https://www.sensepublishers.com/media/41-acting-on-hiv.pdf
Miscellaneous 7
Francis, D.A. (ed.) (2011) Acting on HIV : using drama to create possibilities for change. Rotterdam: Sense Publishers. https://www.sensepublishers.com/media/41-acting-on-hiv.pdf
Miscellaneous 6
Low, Katharine E, 'Creating a space for the individual: different theatre and performance-based approaches to sexual health communication in South Africa.' 2010. Journal of Applied Arts and Health. 1 (1), pp. 111-126 http://www.intellectbooks.co.uk/journals/view-Article,id=8410/
Miscellaneous 5
Oron, B., Sebuwufu, G. and Welbourn, A. (2014). Stepping Stones for Peace and Prosperity. Strategies for Hope Trust and Salamander Trust. http://www.steppingstonesfeedback.org/index.php/page/Resources/gb?resourceid=79
Miscellaneous 4
O'Sullivan, S. and Thomson, K. (1996). Positively women. Hammersmith, London: Pandora. http://trove.nla.gov.au/work/6744826?selectedversion=NBD12580176
Miscellaneous 3
Paine, K., Hart, G., Jawo, M., Ceesay, S., Jallow, M., Morison, L., Walraven, G., McAdam, K. and Shaw, M. (2002). “˜Before we were sleeping, now we are awake”: Preliminary evaluation of the Stepping Stones sexual health programme in The Gambia. African Journal of AIDS Research, 1(1), pp.39-50. http://siteresources.worldbank.org/INTGENDER/Resources/MatthewShawAJARarticle.pdf
Miscellaneous1
Robinson, S., Gardner, S., Loutfy, M., Light, L., Tharao, W., Rourke, S. B., . . . Team, O. C. S. R. (2016). Sexual behaviors among women living with HIV in Ontario, Canada. AIDS Care, 1-6. https://www.ncbi.nlm.nih.gov/pubmed/27607586
Miscellaneous 2
Welbourn, A. (1995). Stepping Stones training programme on HIV, communication and relationship skills. Oxford: Strategies for Hope. http://www.steppingstonesfeedback.org/index.php/About/Stepping_Stones_training_package/gb
Miscellaneous 1
Welbourn, A. (2014). WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment. BMJ, 348(2007), pp.f7601-f7601. http://www.bmj.com/content/348/bmj.f7601
Pregnancy
Social Support, Stigma and Antenatal Depression Among HIV-Infected Pregnant Women in South Africa
Brittain, K., Mellins, C. A., Phillips, T., Zerbe, A., Abrams, E. J., Myer, L., & Remien, R. H. (2017). Social Support, Stigma and Antenatal Depression Among HIV-Infected Pregnant Women in South Africa. AIDS Behav, 21(1), 274-282. doi:10.1007/s10461-016-1389-7, https://www.ncbi.nlm.nih.gov/pubmed/27052843
Pregnancy and linkage to care among women diagnosed with HIV
FitzHarris, L. F., Hollis, N. D., Nesheim, S. R., Greenspan, J. L., & Dunbar, E. K. (2017). Pregnancy and linkage to care among women diagnosed with HIV infection in 61 CDC-funded health departments in the United States, 2013. AIDS Care, 1-8. doi:10.1080/09540121.2017.1282107, https://www.ncbi.nlm.nih.gov/pubmed/28132520
HIV-related stigma in pregnancy
Ion, A., Wagner, A. C., Greene, S., & Loutfy, M. R. (2017). HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care, 29(2), 137-144. doi:10.1080/09540121.2016.1211608, https://www.ncbi.nlm.nih.gov/pubmed/27449254
Presentation for care and antenatal management of HIV in the UK
French, C. E., Thorne, C., Byrne, L., Cortina-Borja, M., & Tookey, P. A. (2016). Presentation for care and antenatal management of HIV in the UK, 2009-2014. HIV Med. doi:10.1111/hiv.12410, https://www.ncbi.nlm.nih.gov/pubmed/27476457
Pregnancy 1
Schalkwijk, S., Colbers, A., Konopnicki, D., Greupink, R., Russel, F. G., Burger, D., & network, P. (2016). First reported use of elvitegravir and cobicistat during pregnancy. AIDS, 30(5), 807-808. https://www.ncbi.nlm.nih.gov/pubmed/26913711
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016;375(18):1726-37.
Talking about HIV
Talking about HIV 8
AIDS Legal Network. If I knew what would happen I would have kept it to myself: Gender violence and HIV. (2012). http://www.endvawnow.org/uploads/browser/files/gender_violence_hiv__report_summary.pdf
Talking about HIV 7
Jasseron C, Mandelbrot L, Dollfus C, et al. Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission. AIDS and Behavior.2011:1-10. http://www.ncbi.nlm.nih.gov/pubmed/22130651
Talking about HIV 6
Moses S, Tomlinson M. The fluidity of disclosure: A longitudinal exploration of women's experience and understanding of HIV disclosure in the context of pregnancy and early motherhood. AIDS Care. 2012. http://www.ncbi.nlm.nih.gov/pubmed/23110311
Talking about HIV 5
Paudel V, Baral KP. Women living with HIV/AIDS (WLHA), battling stigma, discrimination and denial and the role of support groups as a coping strategy: a review of literature. Reprod Health. 2015;12:53. http://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-015-0032-9
Talking about HIV 4
Squire et al. Can an HIV positive woman find true love? Romance in the stories of women living with HIV. Feminism & Psychology 2003 Feb; 13(1), pp. 73–100. http://fap.sagepub.com/content/13/1/73
Talking about HIV 3
Sulstarova B, PogliaMileti F, Mellini L, Villani M, Singy P. HIV disclosure and nondisclosure among migrant women from sub-Saharan Africa living in Switzerland. AIDS Care. 2014:1-7. http://www.ncbi.nlm.nih.gov/pubmed/25297928
Talking about HIV 2
Tiendrebeogo, G., Hejoaka, F., Belem, E., Compaora, P., Wolmarans, L., Soubeiga, A. and Ouangraoua, N. (2013). Parental HIV disclosure in Burkina Faso: Experiences and challenges in the era of HAART. SAHARA-J: Journal of Social Aspects of HIV/AIDS, 10(sup1), pp.S46-S59 http://www.ncbi.nlm.nih.gov/pubmed/23808393
Talking about HIV 1
Van der Zaag, A. C. & McKnight, U. (2016) “Enacting HIV within sero-discordant relationships: a negotiation of multiplicity”. In A. Persson and S. Hughes eds. Couples with Mixed HIV Status: cross-cultural perspectives on serodiscordance (Book series: Social Aspects of HIV). Springer http://www.tandfonline.com/doi/abs/10.1080/01459740.2011.561456